Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche has lost its first case brought against its acne drug Accutane after a New Jersey jury awarded $2.25 million to an Alabama man who claimed that the product had caused his inflammatory bowel disease.
Subscribe to our email newsletter
The jury found that Roche had failed to adequately warn Andrew McCarrell of the drug’s bowel disease risks, and this was a major contributory cause of his illness. The case is the first of approximately 400 which are being brought against the company.
The panel awarded $2.5 million in damages to Mr McCarrell and $119,000 for past medical expenses. However, the jurors found that Roche did not violate New Jersey consumer fraud law in its marketing of Accutane.
Roche said that it intends to appeal the verdict.